MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-03-0020223
Nigella Pharmaceuticals Private Limited
Nigella Pharmaceuticals Private Limited - trading in Haridwar, Uttarakhand, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹31.17 Lakh
▲ 61% YoY
Net loss · FY 2025
₹1.29 Lakh
Net margin -4.1%
EBITDA · FY 2025
-₹11,792
EBITDA margin -0.4%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹5.52 Lakh
Secured borrowings
Company age
15 yrs
Est. 2011
Directors on board
3
As per MCA filings
About Nigella Pharmaceuticals Private Limited
Data last updated:
Nigella Pharmaceuticals Private Limited is a private limited company based in Haridwar, Uttarakhand, India. It operates in the retail trade segment of the trading and commerce sector. It was incorporated on 05 September 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U15122UR2011PTC033651. Its GSTIN is 09AADCN7542C2ZI (Uttar Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Mohd Kafeel Amjad and Mohd Shakeel Amjad.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Q – 116 3rd Phase Shivalik Nagar Bhel, Haridwar, Uttarakhand, India – 249403.
As per the financials filed for FY 2025, the company reported a revenue of ₹31.17 Lakh, a growth of 61% compared to the previous year. For the same year it recorded a net loss of ₹1.29 Lakh (net margin -4.1%) and EBITDA of -₹11,792 (EBITDA margin -0.4%). Revenue has grown at a compounded annual rate (CAGR) of 38% over three years.
As per MCA filings, the company has open charges of ₹5.52 Lakh on record.
Nigella Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-03-0020223). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U15122UR2011PTC033651
Registration Number 033651
Incorporation Date 05 September 2011
ROC Uttarakhand
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UP-03-0020223
Recognitions & Rankings of Nigella Pharmaceuticals
Contact details
Nigella Pharmaceuticals Private Limited's registered office is in Haridwar, Uttarakhand. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressQ – 116 3rd Phase Shivalik Nagar Bhel, Haridwar, Uttarakhand, India – 249403
- IndustryTrading, Retailers, Retail Trading, Other Wholesale, Wholesale
To see the full contact details of Nigella Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Nigella Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Nigella Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Nigella Pharmaceuticals Private Limited, buy the company report.
Financials of Nigella Pharmaceuticals Private Limited
FY 2025 filings availableNigella Pharmaceuticals Private Limited reported revenue of ₹31.17 Lakh (up 61% YoY) for FY 2025.
Revenue · FY 2025
₹31.17 Lakh ▲ 61%
Net loss · FY 2025
₹1.29 Lakh margin -4.1%
EBITDA · FY 2025
-₹11,792 margin -0.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 61%
3 years · compounded
▲ 38%
EBITDA CAGR growth
1 year
▲ 47%
3 years · compounded
▼ 52%
5 years · compounded
▲ 17%
Revenue has grown at a compounded annual rate (CAGR) of 38% over three years, including 61% growth in the latest year. EBITDA rose 47% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹11,792 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.29 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.4% | ||||
| Net Profit Margin | -4.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nigella Pharmaceuticals Private Limited, buy the company report.
Board of directors of Nigella Pharmaceuticals Private Limited
Nigella Pharmaceuticals has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohd Kafeel Amjad | Director | 23 Dec 2011 | 14 Years 10 Months | Current |
| Mohd Shakeel Amjad | Director | 27 May 2019 | 7 Years 5 Months | Current |
| Mohammad Sahabuddin | Director | 23 Dec 2011 | 14 Years 10 Months | Current |
Peer comparison
Nigella Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nuera Pharmaceuticals Private Limited | ₹31.23 Lakh (FY 2025) | 73.0% | Bhopal, Madhya Pradesh, India | |||
| Biotical Pharmaceuticals Private Limited | ₹31.18 Lakh (FY 2025) | -54.0% | Ahmedabad, Gujarat, India | |||
| Nigella Pharmaceuticals Private Limitedthis company | ₹31.17 Lakh (FY 2025) | -₹1.29 Lakh | -4.1% | 61.0% | Haridwar, Uttarakhand, India | |
| Amiranz Pharmaceuticals Private Limited | ₹31.05 Lakh (FY 2024) | 26.0% | Kushinagar, Uttar Pradesh, India | |||
| Rainvis Pharmaceuticals Private Limited | ₹31.04 Lakh (FY 2019) | -4.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Nigella Pharmaceuticals Private Limited, buy the company report.
Auditor
Nigella Pharmaceuticals Private Limited is audited by SIDDIQUI AND COMPANY for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SIDDIQUI AND COMPANY | FY 2017 | 008196C |
Shareholding
The shareholding of Nigella Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Nigella Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹5.52 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Oct 2021 | 100537696 | Hdfc Bank Limited | ₹5.52 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Nigella Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nigella Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Nigella Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AADCN7542C2ZI | Uttar Pradesh | Active | 22 Mar 2020 |
To see the full GST registrations and return filing status of Nigella Pharmaceuticals Private Limited, buy the company report.
Recent activity
Nigella Pharmaceuticals Private Limited has 6 board changes on record since 2011: 3 appointments and 3 cessations. The latest: Faraaz Ahmad ceased to be Whole-Time Director on 27 May 2019.
AGM
Nigella Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Nigella Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttarakhand.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 5.52 Lakh with Charge ID 100537696 was registered on 28 Oct 2021.
Ceased
Faraaz Ahmad ceased to be Whole-Time Director.
Ceased
Izman Khan ceased to be Whole-Time Director.
Appointed
Mohd Shakeel Amjad was appointed as Director.
Ceased
Zafar Hashmi ceased to be Director.
Appointed
Mohammad Sahabuddin was appointed as Director.
Appointed
Mohd Kafeel Amjad was appointed as Director.
Incorporation
05 Sep 2011
Nigella Pharmaceuticals Private Limited was registered on 05 Sep 2011 with Roc Uttarakhand & aged 15 years 2 months as per MCA records.
Frequently asked questions
Nigella Pharmaceuticals is an active private limited company based in Haridwar, Uttarakhand, India. The company works in retailers, within the trading industry. It was incorporated on 05 September 2011 (15+ years old) and is registered under CIN U15122UR2011PTC033651.
Nigella Pharmaceuticals has 3 current directors:
- Mohd Kafeel Amjad - Director
- Mohd Shakeel Amjad - Director
- Mohammad Sahabuddin - Director
The latest financial statements of Nigella Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Nigella Pharmaceuticals is 09AADCN7542C2ZI, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Nigella Pharmaceuticals is U15122UR2011PTC033651. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nigella Pharmaceuticals was incorporated on 05 September 2011, making it 15+ years old. It is registered with the Registrar of Companies, Uttarakhand.
The peers of Nigella Pharmaceuticals by revenue are Nuera Pharmaceuticals Private Limited, Biotical Pharmaceuticals Private Limited, Amiranz Pharmaceuticals Private Limited, Rainvis Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Faraaz Ahmad ceased to be Whole-Time Director on 27 May 2019. Izman Khan ceased to be Whole-Time Director on 27 May 2019. Mohd Shakeel Amjad was appointed as Director on 27 May 2019. Nigella Pharmaceuticals has 6 board changes on record in total.
Yes, Nigella Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-03-0020223).
The registered office of Nigella Pharmaceuticals is at Q – 116 3rd Phase Shivalik Nagar Bhel, Haridwar, Uttarakhand, India – 249403.
Nigella Pharmaceuticals operates in the trading industry, in the retailers segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages